English

This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.

This Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

Clinicians looking for free CME/CNE credits can access the University of Washington’s Hepatitis C Online course. There are seven interactive self-study modules available ranging from screening and diagnosis to treatment of specific populations.

This campaign creates a national storybank featuring real people living with hepatitis B who share their stories and put a human face on this serious disease. They hope to decrease stigma and discrimination and promote testing, immunization and treatment for hepatitis B to save lives. A new story will be featured each month during 2017. 

This fact sheet provides hepatitis C information for Veterans.

This interactive session provides information about a unique government-community partnership, new multilingual hepatitis B educational resources, and local efforts to increase awareness and encourage hepatitis B testing. Panelists discuss outreach, screening, vaccination, and linkage to care strategies to address hepatitis B among high-risk populations in Philadelphia, Minneapolis, and other communities.

This session focuses on hepatitis B global epidemiology, as well as hepatitis D testing, management and treatment. This interactive session discusses how we can work together to improve awareness and testing for HBV co-infection.

Information on how to stop and prevent stigma.

Stigma stops the majority of people living with viral hepatitis from enjoying the quality of life they deserve. As a community, we must come together to challenge misconceptions and be empowered to act on violations. We asked people living with viral hepatitis to share their experiences and say stop to stigma.

Information and case studies on acute Hepatitis B infections in the U.S.